NCT01640457View on ClinicalTrials.gov

Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 1, 2018

Study Completion Date

June 14, 2021

Conditions
Intervertebral Disc DisplacementIntervertebral Disc Degeneration
Interventions
DRUG

NOVOCART® Disc plus

Autologous Disc Chondrocyte Transplantation System (ADCT)

DEVICE

NOVOCART® Disc basic

ADCT (Media with no active cell component)

Trial Locations (10)

6020

University Hospital for Neurosurgery Innsbruck, Innsbruck

13353

Charité Universitätsmedizin, Berlin

14050

DRK Kliniken Berlin Westend, Berlin

37075

Universitätsmedizin, Göttingen

40225

University Hospital Duesseldorf, Düsseldorf

48145

St. Franziskus Hospital, Münster

55743

SHG Klinikum, Idar-Oberstein

76133

Städtisches Klinikum, Karlsruhe

82418

Berufsgenossenschaftliche Unfallklinik, Murnau am Staffelsee

06112

"Hospital BG-Kliniken Bergmannstrost", Halle

All Listed Sponsors
lead

Tetec AG

INDUSTRY

NCT01640457 - Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine | Biotech Hunter | Biotech Hunter